These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9517520)

  • 21. Cisapride treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled trial.
    Hausken T; Berstad A
    Scand J Gastroenterol; 1992; 27(3):213-7. PubMed ID: 1502484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial.
    Rösch W
    Scand J Gastroenterol; 1987 Mar; 22(2):161-4. PubMed ID: 3554491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
    Jian R; Ducrot F; Ruskone A; Chaussade S; Rambaud JC; Modigliani R; Rain JD; Bernier JJ
    Dig Dis Sci; 1989 May; 34(5):657-64. PubMed ID: 2653742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breathing exercises with vagal biofeedback may benefit patients with functional dyspepsia.
    Hjelland IE; Svebak S; Berstad A; Flatabø G; Hausken T
    Scand J Gastroenterol; 2007 Sep; 42(9):1054-62. PubMed ID: 17710670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
    Corinaldesi R; Stanghellini V; Raiti C; Rea E; Salgemini R; Barbara L
    Gut; 1987 Mar; 28(3):300-5. PubMed ID: 3552906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W
    Clin Ther; 1994; 16(3):437-45. PubMed ID: 7923310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
    Rezende-Filho J; Di Lorenzo C; Dooley CP; Valenzuela JE
    Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of irritated stomach with cisapride. A placebo-controlled double-blind study].
    Rösch W; Panijel M; Schwarz W; Dilla H; Giesecke HJ; Gabriel H; Kullik R; Leber W; Weitendorff F; Daake H
    Fortschr Med; 1986 Jul; 104(27-28):544-6. PubMed ID: 3527910
    [No Abstract]   [Full Text] [Related]  

  • 30. Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride.
    Hausken T; Berstad A
    Scand J Gastroenterol; 1992 May; 27(5):427-32. PubMed ID: 1529280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials in nonulcer dyspepsia (NUD): a cautionary note. A closer look at "a double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia".
    Champion MC
    Can J Gastroenterol; 1997 Mar; 11(2):125-6. PubMed ID: 9113811
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life.
    Abell TL; Cutts TF; Cooper T
    Scand J Gastroenterol Suppl; 1993; 195():60-3; discussion 63-4. PubMed ID: 8516661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis].
    Scalon P; Di Mario F; Meggiato T; Basso D; Battaglia G; Vianello F; Fogar P; Del Favero G
    Minerva Gastroenterol Dietol; 1992; 38(2):101-4. PubMed ID: 1391144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vagal tone and meal-induced abdominal symptoms in healthy subjects.
    Hjelland IE; Hausken T; Svebak S; Olafsson S; Berstad A
    Digestion; 2002; 65(3):172-6. PubMed ID: 12138322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisapride and gastric emptying of a solid meal in dyspeptic diabetics without autonomic neuropathy and in healthy volunteers.
    Brogna A; Ferrara R; Scornavacca G; Lombardo A; Bucceri A; Catalano F; Paradisi V; Onorato S
    Eur J Clin Pharmacol; 1989; 37(4):411-3. PubMed ID: 2598976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors, co-medication, and concomitant diseases: their influence on the outcome of therapy with cisapride.
    Fehr HF
    Scand J Gastroenterol Suppl; 1993; 195():40-5; discussion 45-6. PubMed ID: 8516657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia.
    Haug TT; Svebak S; Hausken T; Wilhelmsen I; Berstad A; Ursin H
    Psychosom Med; 1994; 56(3):181-6. PubMed ID: 8084961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting dose selection and outcome of cisapride treatment for dyspepsia in primary care. The Austro-Cis Study Group.
    Brunner H
    Aliment Pharmacol Ther; 1996 Aug; 10(4):587-94. PubMed ID: 8853763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
    Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
    Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.